Nascent Biotech, Inc. Email Format
Biotechnology ResearchCalifornia, United States0-1 Employees
Nascent Biotech, Inc. is a biotechnology research company based in San Diego, California, founded in 2014. Its principal focus is the development of monoclonal antibody therapies, notably Pritumumab, which targets a proprietary antigen on cancer cells with the goal of treating brain and pancreatic cancers. The company operates within the immunotherapy segment of oncology, emphasizing strategies that modulate the body's immune response to combat disease. Nascent Biotech collaborates with scientific advisors and external partners to advance its research and clinical initiatives, including activities that support characterization of molecular structure and collaboration with healthcare organizations for potential clinical trials. Recent developments include additions to its scientific advisory team and partnerships intended to define the higher order molecular structure of its antibody candidate.“ } } {